FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1520286824> ?p ?o ?g. }

• W1520286824 endingPage "89" @default.
• W1520286824 startingPage "74" @default.
• W1520286824 abstract "The success of nanomedicine as a new strategy for drug delivery and targeting prompted the interest in developing approaches toward basic and clinical neuroscience. Despite enormous advances on brain research, central nervous system (CNS) disorders remain the world's leading cause of disability, in part due to the inability of the majority of drugs to reach the brain parenchyma. Many attempts to use nanomedicines as CNS drug delivery systems (DDS) were made; among the various non-invasive approaches, nanoparticulate carriers and, particularly, polymeric nanoparticles (NPs) seem to be the most interesting strategies. In particular, the ability of poly-lactide-co-glycolide NPs (PLGA-NPs) specifically engineered with a glycopeptide (g7), conferring to NPs' ability to cross the blood brain barrier (BBB) in rodents at a concentration of up to 10% of the injected dose, was demonstrated in previous studies using different routes of administrations. Most of the evidence on NP uptake mechanisms reported in the literature about intracellular pathways and processes of cell entry is based on in vitro studies. Therefore, beside the particular attention devoted to increasing the knowledge of the rate of in vivo BBB crossing of nanocarriers, the subsequent exocytosis in the brain compartments, their fate and trafficking in the brain surely represent major topics in this field." @default.
• W1520286824 created "2016-06-24" @default.
• W1520286824 creator A5001556609 @default.
• W1520286824 creator A5001902247 @default.
• W1520286824 creator A5003113988 @default.
• W1520286824 creator A5006621617 @default.
• W1520286824 creator A5013449807 @default.
• W1520286824 creator A5027655728 @default.
• W1520286824 creator A5048439103 @default.
• W1520286824 creator A5059382794 @default.
• W1520286824 creator A5060025616 @default.
• W1520286824 creator A5076419622 @default.
• W1520286824 date "2015-06-19" @default.
• W1520286824 modified "2023-10-10" @default.
• W1520286824 title "Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles" @default.
• W1520286824 cites W1525450470 @default.
• W1520286824 cites W1549213315 @default.
• W1520286824 cites W1565184249 @default.
• W1520286824 cites W1595083713 @default.
• W1520286824 cites W1630481045 @default.
• W1520286824 cites W1972388591 @default.
• W1520286824 cites W1975495109 @default.
• W1520286824 cites W1978693401 @default.
• W1520286824 cites W1978948741 @default.
• W1520286824 cites W1980110116 @default.
• W1520286824 cites W1986095368 @default.
• W1520286824 cites W1986129921 @default.
• W1520286824 cites W1988032849 @default.
• W1520286824 cites W1989301056 @default.
• W1520286824 cites W1989435843 @default.
• W1520286824 cites W1994677316 @default.
• W1520286824 cites W2003110090 @default.
• W1520286824 cites W2004362675 @default.
• W1520286824 cites W2004544254 @default.
• W1520286824 cites W2005574904 @default.
• W1520286824 cites W2007483105 @default.
• W1520286824 cites W2007797957 @default.
• W1520286824 cites W2011362934 @default.
• W1520286824 cites W2014692143 @default.
• W1520286824 cites W2018121350 @default.
• W1520286824 cites W2018522439 @default.
• W1520286824 cites W2019980666 @default.
• W1520286824 cites W2031892070 @default.
• W1520286824 cites W2039212827 @default.
• W1520286824 cites W2040894400 @default.
• W1520286824 cites W2042273549 @default.
• W1520286824 cites W2042948773 @default.
• W1520286824 cites W2046133662 @default.
• W1520286824 cites W2051340348 @default.
• W1520286824 cites W2057087692 @default.
• W1520286824 cites W2059685204 @default.
• W1520286824 cites W2060125421 @default.
• W1520286824 cites W2061264254 @default.
• W1520286824 cites W2065378127 @default.
• W1520286824 cites W2069335752 @default.
• W1520286824 cites W2072167784 @default.
• W1520286824 cites W2077850064 @default.
• W1520286824 cites W2088106005 @default.
• W1520286824 cites W2090356302 @default.
• W1520286824 cites W2094665624 @default.
• W1520286824 cites W2105680795 @default.
• W1520286824 cites W2108232919 @default.
• W1520286824 cites W2115271408 @default.
• W1520286824 cites W2115629722 @default.
• W1520286824 cites W2121776150 @default.
• W1520286824 cites W2129144690 @default.
• W1520286824 cites W2135513848 @default.
• W1520286824 cites W2140992384 @default.
• W1520286824 cites W2145206503 @default.
• W1520286824 cites W2145623314 @default.
• W1520286824 cites W214589945 @default.
• W1520286824 cites W2148992136 @default.
• W1520286824 cites W2154177113 @default.
• W1520286824 cites W2161396884 @default.
• W1520286824 cites W2167221791 @default.
• W1520286824 cites W2167360442 @default.
• W1520286824 cites W2167489650 @default.
• W1520286824 cites W2167739272 @default.
• W1520286824 cites W2171865323 @default.
• W1520286824 cites W2180851115 @default.
• W1520286824 cites W2374159384 @default.
• W1520286824 cites W4247546166 @default.
• W1520286824 cites W2123348541 @default.
• W1520286824 doi "https://doi.org/10.3390/pharmaceutics7020074" @default.
• W1520286824 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4491652" @default.
• W1520286824 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26102358" @default.
• W1520286824 hasPublicationYear "2015" @default.
• W1520286824 type Work @default.
• W1520286824 sameAs 1520286824 @default.
• W1520286824 citedByCount "40" @default.
• W1520286824 countsByYear W15202868242015 @default.
• W1520286824 countsByYear W15202868242016 @default.
• W1520286824 countsByYear W15202868242017 @default.
• W1520286824 countsByYear W15202868242018 @default.
• W1520286824 countsByYear W15202868242019 @default.
• W1520286824 countsByYear W15202868242020 @default.
• W1520286824 countsByYear W15202868242021 @default.
• W1520286824 countsByYear W15202868242022 @default.

• next